Learn on Demand

Learn on Demand

New Insulin Therapies
Presenter: Christopher Johnson, PharmD, MEd Kaci Thiessen, PharmD, BCACP
View Activity Information

Knowledge Gap: 
The purpose of this activity is to educate healthcare providers with the most up-to-date information on New Insulin Therapies. 

Target Audience
The target audience includes all healthcare professionals such as physicians, nurses, pharmacists and allied health professionals who would like to learn about New Insulin Therapies and how it pertains to their respective profession.

Release and Expiration Dates
3/7/2018 -3/7/2021
Objectives:
  1. Describe pharmacokinetic differences in new insulin therapies.
  2. Identify patient-specific factors that may benefit from initiation to a new insulin agent.
  3. Explain appropriate combinations of insulin and non-insulin antihyperglycemic medications.
References:

  1. Schwartz SS, et al. Diabetes Care. 2016;39(2):179-86
  2. Tobin GS, et al. Int J Clin Pract, 2012;66(12):1147-57.
  3. Lovre D. J Diabetes Complications 2015;29:295-301
  4. ADA, American Diabetes Association
  5. AACE/ACE, American Association of Clinical Endocrinologists/ American College of Endocrinology
  6. Diabetes Care 2018; 41(Suppl. 1): S1-S159.
  7. Endocr Pract.2017,doi:10.4158/EP161682.CS
  8. Diabetes Care 2018; 41(Suppl. 1): S1-S159.
  9. FDA approves Basaglar, the first “follow-on” insulin glargine product to treat diabetes. FDA News Release. Dec 2016.
  10. Biological products. US Food and Drug Administration website. Updated Aug 2015.
  11. Binder C, et al. Diabetes Care. 1984;7:188-199.                  
  12. Tresiba [package insert]. Novo Nordisk Inc; Dec 2016.
  13. Toujeo [package insert]. Sanofi-Aventis; Sep 2015.
  14. Humulin R [package insert]. Eli Lilly and Company; Jul 2016.
  15. Becker R, et al. Diabetes Care 2015;38:637-643.
  16. Clements JN, Bello N. Am J Health-Syst Pharm 2016;73:359-66.
  17. Zinman B, et al. Diabetes Care 2012;35:2464–2471.
  18. Davies, M, et al. Diabetes Care 2005;28:1282–1288.
  19. Riddle MC, et al. Diabetes Obes Metab 2014:16;396-402.
  20. Kitabchi AE, et al. Am J Med Sci 2012;344(2):136-41.
  21. Fiasp: EPAR – Product Information. Novo Nordisk Inc. Mar 2017.
  22. Cobry E, et al. Diabetes Technol Ther 2010;12(3):173-7.
  23. Endocr Pract.2017,doi:10.4158/EP161682.CS
  24. Gourgari E, et al. J Diabetes Complications 2017; pii: S1056-8727(17)30200-3
  25. Vilsbøll T, et al. Diabetes Obes Metab 2010;12(2):167-77.
  26. Rosenstock J, et al. Diabetes Obes Metab 2009;11(12):1145-52.
  27. Hollander P, et al. Diabetes Obes Metab 2011;13(3):268-75
  28. Gourgari E, et al. J Diabetes Complications 2017; pii: S1056-8727(17)30200-3
  29. Triplitt C, Solb-Herrera C. Diabetes Educ. 2015;41(suppl1):35S-46S.
  30. Semaglutide: briefing document 209637. Sanofi-Aventis; Oct 2017.
  31. Aroda VR, et al. Diabetes Care 2016;39(11):1972-1980.
  32. Raccah D, et al. J Diabetes Complicat 2014;28(1):40-4.
  33. Anderson S.L. and J.M. Trujillo. Diabetes Spectrum 2016; 29(3)
  34. Tang H, et al. Diabetes Obes Metab 2016; 19(1):142–147

Biographical Info

Christopher Johnson, PharmD, Med

Clinical Pharmacist at UAMS Family Medical Center
Bachelor of Science in Biology from Oregon State University; 2010.
Doctor of Pharmacy from Concordia University Wisconsin School of Pharmacy; 2015. PGY-1 Practice & Academic Leadership Residency at Concordia University Wisconsin School of Pharmacy; 2015-2017.
Concordia University Wisconsin School of Pharmacy Preparing Future Pharmacy Faculty Certificate Program; 2017.
Master of Science in Education from Concordia University Wisconsin; 2017.

Kaci Thiessen, PharmD, BCACP

Clinical Pharmacist at UAMS Family Medical Center; Little Rock, AR
Doctor of Pharmacy from University of Missouri-Kansas City; 2014
PGY1 Pharmacy Practice Residency at Via Christi Hospitals in Wichita, KS; 2014-15
University of Kansas Pharmacy Resident Teaching and Learning Curriculum Program; 2014-15
PGY2 Ambulatory Care Residency at University of Oklahoma-Tulsa in Tulsa, OK; 2015-16
University of Oklahoma Advanced Teaching Skills Program; 2015-16

Speaker Disclosures:
The planners, speakers, moderators, peer reviewers and /or panelists of this CE activity have no relevant financial relationships with commercial interests to disclose.

Planners: 
Kim Miller  
Susan Smith Dodson

Speaker:
Christopher Johnson, PharmD, Med
Kaci Thiessen, PharmD, BCACP

Peer Reviewers: 
Kim Miller, MCHES

Instructions to obtain credit:

1.       Launch the activity 
2.       View the entire activity online 
3.       Complete the post-test 
           (must pass the post-test with a score of 65% to receive credit). 
           You may retake the post-test if you do not receive a passing score.
4.       Complete Evaluation 
Print certificate or transcript (Available in the “My Profile” tab).

Direct Provider Statement
In support of improving patient care, University of Arkansas for Medical Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statement 
The University of Arkansas for Medical Science Office of Continuing Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Arkansas for Medical sciences designates this enduring activity for a maximum of 1.00 ANCC contact hours. Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation materials.

Disclosure Policy statement

It is the policy of the University of Arkansas for Medical Sciences Office of Continuing Education to ensure balance, independence, objectivity and scientific rigor in all provided and jointly provided educational activities.  All individuals who are in a position to control the content of the educational activity (course/activity, directors, planning committee members, staff, teachers, or authors of CE) must disclose all relevant financial relationships they have with any commercial interest(s) as well as the nature of the relationship.  Financial relationships of immediate family members must also be disclosed, if the nature of the relationship(s) could influence the objectivity of the individual in a position to control the content.  The ACCME describes relevant financial relationships as those in any amount occurring within the past 12 months that create a conflict of interest.  Individuals who refuse to disclose are disqualified from participation in the development, management, presentation, or evaluation of the CE activity.

UAMS Office of Continuing Education

4301 W. Markham #525
Little Rock, AR 72205
Phone: 501-661-7962 Fax: 501-661-7968

Learn On Demand Contact Us:
For information regarding this educational activity or website, please contact

Center for Distance Health
4301 W. Markham #519
Little Rock, AR 72205
Toll Free: 1-855-234-3348
Email: cdheducation@uams.edu


Type:  Internet Activity (Enduring Material)
86 Registered Users
Credits
1 Hours> Non-Accredited
1 Credits> Accreditation Council for Continuing Medical Education> AMA PRA Category 1 Credit™
1 Contact Hours> American Nurses Credentialing Center> ANCC
1 CECH, 1 CECH> National Commission for Health Education Credentialing, Inc. > CHES